Inscription à l’infolettre

Publication

Sordaricin antifungal agents.

Compounds based on sordaricin were prepared via organometallic addition onto a fully protected sordaricin aldehyde. The fungal growth inhibition profiles for these compounds were established and the results are presented here. The synthesis of homologated sordaricin as well as ether and ester derivatives is presented, and structural rearrangement products upon oxidation. These compounds were evaluated as agents to inhibit fungal growth.

Date de publication
10 février 2003
Chercheur(euse)s
Quesnelle CA, Gill P, Dodier M, St Laurent D, Serrano-Wu M, Marinier A, Martel A, Mazzucco CE, Stickle TM, Barrett JF, Vyas DM, Balasubramanian BN
Référence PubMed
Bioorg. Med. Chem. Lett. 2003;13(3):519-24
ID PubMed
12565963
Affiliation
Bristol-Myers Squibb Pharmaceutical Research Institute, 100, boul. de l’Industrie, Candiac, Québec, Canada J5R 1J1. claude.quesnelle@bms.com